Stockreport

20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress

 (AIDX) 
PDF Full Year 2025 Revenue of $2.0 Million, up 17% from 2024 Gross Profit Increased 68% in FY 2025 and Gross Margin Expanded 900 bps State-Funded Firefighter Cancer Screen [Read more]